Product News and Recalls

Pfizer to Merge with Allergan in $150 Billion Deal

Two pharmaceutical giants are set to merge in what will be the pharmaceutical industry’s largest ever deal, Reuters reports. While the $150 billion transaction will result in Allergan technically buying Pfizer, Pfizer’s CEO is set to head the combined company.

While the new deal marks a success for Pfizer, the New York–based company still struggles with product liability lawsuits filed over several of its drugs. Nearly 300 Zoloft birth defect lawsuits are pending in a multidistrict litigation in the U.S. District Court for the District of Eastern Pennsylvania. These lawsuits have been filed by women who claim taking the popular antidepressant during pregnancy led them to give birth to children with congenital defects.

Additionally, Pfizer is facing a growing number of Lipitor lawsuits filed by women who allege the drug caused them to develop diabetes. Almost 3,000 Lipitor lawsuits are currently pending in a South Carolina multidistrict litigation, and that number is expected to double over the coming year.

Finally, Pfizer continues to deal with lawsuits filed over its best-selling erectile dysfunction drug, Viagra. Plaintiffs in Viagra melanoma lawsuits claim Pfizer knew of the skin cancer risk its product posed, yet failed to properly warn doctors and patients.

Speak to your doctor if you have any concerns about the medications you are taking. If you were injured after taking any of these drugs, you should contact the pharmaceutical attorneys at Lopez McHugh today to receive a free consultation.